Search Results - "Repka TL"

Intraperitoneal administration of NK-92 improves survival in xenografts of early and established ovarian cancer models.

Authors: Marcus, Paula Warrington, Jenny Zhang, Michael et al.

Source: PLoS ONE. 4/20/2026, Vol. 21 Issue 4, p1-14. 14p.

Harnessing the power of memory-like NK cells to fight cancer.

Authors: Foo, Yun Yan Tiah, Angelina Aung, Shuh Wen

Source: Clinical & Experimental Immunology. Jun2023, Vol. 212 Issue 3, p212-223. 12p. 3 Diagrams, 2 Charts.

Feasibility of Low-Dose Interleukin-2 Therapy Following T-Cell-Depleted Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation From HLA-Matched or -Mismatched Family Member Donors.

Authors: Rizzieri, David A. Crout, Christopher Storms, Robert et al.

Source: Cancer Investigation. Jan2011, Vol. 29 Issue 1, p56-61. 6p.

Natural killer cells in clinical development as non-engineered, engineered, and combination therapies.

Authors: Lamers-Kok, Nina Panella, Denise Georgoudaki, Anna-Maria et al.

Source: Journal of Hematology & Oncology. 11/8/2022, Vol. 15 Issue 1, p1-55. 55p.

In vivo Anti-Cancer Effects of Resveratrol Mediated by NK Cell Activation.

Authors: Lee, Yoojin Shin, Heewook Kim, Jongsun

Source: Journal of Innate Immunity. 2021, Vol. 13 Issue 2, p94-106. 13p.

Natural Killer Cell-Based Cancer Immunotherapy: A Review on 10 Years Completed Clinical Trials.

Authors: Suen, Wade Chun-Wai Lee, Wayne Yuk-Wai Leung, Kam-Tong et al.

Source: Cancer Investigation. 2018, Vol. 36 Issue 8, p431-457. 27p.

Efficacy of the neurokinin-1 receptor antagonist aprepitant in children with cyclical vomiting syndrome.

Authors: Cristofori, F. Thapar, N. Saliakellis, E. et al.

Source: Alimentary Pharmacology & Therapeutics. Aug2014, Vol. 40 Issue 3, p309-317. 9p. 2 Charts, 1 Graph.

Hunting for clinical translation with innate-like immune cells and their receptors.

Authors: Scheper, W Gründer, C Straetemans, T et al.

Source: Leukemia (08876924). Jun2014, Vol. 28 Issue 6, p1181-1190. 10p.

Immunotherapy with autologous tumour antigen-coated microbeads (large multivalent immunogen), IL-2 and GM-CSF in dogs with spontaneous B-cell lymphoma.

Authors: Henson, M. S. Curtsinger, J. M. Larson, V. S. et al.

Source: Veterinary & Comparative Oncology. Jun2011, Vol. 9 Issue 2, p95-105. 11p. 3 Charts.

IL-2 Regulates SEB Induced Toxic Shock Syndrome in BALB/c Mice.

Authors: Khan, Aslam Ali Priya, Shilpee Saha, Bhaskar

Source: PLoS ONE. 2009, Vol. 4 Issue 12, p1-6. 6p.

The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin's lymphoma.

Authors: Yinlee Yoong Porrata, Luis F. Inwards, David J. et al.

Source: Leukemia & Lymphoma. Sep2005, Vol. 46 Issue 9, p1287-1294. 8p.

REVIEW ARTICLES Clinical Experience with Trastuzumab (Herceptin).

Authors: Vogel, Charles L. Franco, Sandra X.

Source: Breast Journal. Nov2003, Vol. 9 Issue 6, p452-462. 11p.

Ameliorating effects and mechanisms of chronic electroacupuncture at ST36 in a rodent model of dyspepsia induced by cisplatin.

Authors: Liu, Yi Zhang, Sunjuan Ye, Feng et al.

Source: Neurogastroenterology & Motility. Jan2019, Vol. 31 Issue 1, pN.PAG-N.PAG. 1p.

Pharmacologically upregulated carcinoembryonic antigen-expression enhances the cytolytic activity of genetically-modified chimeric antigen receptor NK-92MI against colorectal cancer cells.

Authors: Shiozawa, Masayuki Chang, Chuan-Hsin Huang, Yi-Chun et al.

Source: BMC Immunology. 8/3/2018, Vol. 19 Issue 1, pN.PAG-N.PAG. 1p.

Interleukin signaling in the regulation of natural killer cells biology in breast cancer.

Authors: Xu J Gao H Azhar MS et al.

Source: Frontiers in immunology [Front Immunol] 2024 Sep 24; Vol. 15, pp. 1449441. Date of Electronic Publication: 2024 Sep 24 (Print Publication: 2024).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

The role and novel use of natural killer cells in graft-versus-leukemia reactions after allogeneic transplantation.

Authors: Hadjis AD McCurdy SR

Source: Frontiers in immunology [Front Immunol] 2024 May 16; Vol. 15, pp. 1358668. Date of Electronic Publication: 2024 May 16 (Print Publication: 2024).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Interleukin-2 is required for NKp30-dependent NK cell cytotoxicity by preferentially regulating NKp30 expression.

Authors: Kim N Yi E Lee E et al.

Source: Frontiers in immunology [Front Immunol] 2024 Apr 18; Vol. 15, pp. 1388018. Date of Electronic Publication: 2024 Apr 18 (Print Publication: 2024).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Potentiation of natural killer cells to overcome cancer resistance to NK cell-based therapy and to enhance antibody-based immunotherapy.

Authors: Fantini M Arlen PM Tsang KY

Source: Frontiers in immunology [Front Immunol] 2023 Nov 24; Vol. 14, pp. 1275904. Date of Electronic Publication: 2023 Nov 24 (Print Publication: 2023).

Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

The application of autologous cancer immunotherapies in the age of memory-NK cells.

Authors: Lizana-Vasquez GD Torres-Lugo M Dixon RB et al.

Source: Frontiers in immunology [Front Immunol] 2023 May 02; Vol. 14, pp. 1167666. Date of Electronic Publication: 2023 May 02 (Print Publication: 2023).

Publication Type: Journal Article; Review; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

A NK Cell Odyssey: From Bench to Therapeutics Against Hematological Malignancies.

Authors: Ramos-Mejia V Arellano-Galindo J Mejía-Arangure JM et al.

Source: Frontiers in immunology [Front Immunol] 2022 Apr 14; Vol. 13, pp. 803995. Date of Electronic Publication: 2022 Apr 14 (Print Publication: 2022).

Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE